First humans receive experimental Graves' disease treatment
Disease control
Recruiting now
This is the first human study testing a new drug called MER511 for Graves' disease, an autoimmune condition affecting the thyroid. Researchers will give the drug to 100 adults with Graves' disease to check for side effects and see how their bodies process it. The study will test …
Phase: PHASE1 • Sponsor: Merida Biosciences • Aim: Disease control
Last updated Apr 02, 2026 01:56 UTC